# 주식창 (주식, 증권시세, 주식비타민) vs 미니스탁

The clearest difference is rating: 미니스탁 at 4.0 against 주식창 (주식, 증권시세, 주식비타민)'s 2.9. 미니스탁 also leads on in-app purchases (none vs 5) and ads (none vs shown). 주식창 (주식, 증권시세, 주식비타민)'s advantage is review sentiment (81% vs 64%) and iOS requirement (13.0 vs 15.0). On price, ratings volume, update cadence and device support there is nothing between them.

Both are free to download. 주식창 (주식, 증권시세, 주식비타민) sells 5 one-off in-app purchases. 미니스탁 asks for nothing beyond the download.

미니스탁 holds the better App Store score, 4.0 against 2.9. Both are backed by a comparable volume of ratings — 8 and 22 respectively. Written reviews complicate that: 81% of 주식창 (주식, 증권시세, 주식비타민)'s written reviews are positive against 64% of 미니스탁's, so the app with the better star average is not the one people write more warmly about.

주식창 (주식, 증권시세, 주식비타민) ships an update every 2 weeks, 미니스탁 monthly. Both last shipped on November 16, 2026.

## The numbers

| Metric | 주식창 (주식, 증권시세, 주식비타민) | 미니스탁 |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [2.9 (8 ratings)](https://appshunter.io/ios/app/id577658269/reviews) | **[4.0 (22 ratings)](https://appshunter.io/ios/app/id1517001633/reviews)** |
| Number of ratings | 8 | **22** |
| Positive reviews | **81.5% of reviews** | 64.3% of reviews |
| In-app purchases | Yes | **No** |
| Ads | Yes | **No** |
| Update frequency | **Every 2 weeks** | Monthly |
| Monetization | Free with in-app purchases | **Ad-supported** |
| Size | 71 MB | 216 MB |
| Requires iOS | **13.0** | 15.0 |
| Devices | iPhone, iPod | iPhone, iPod |
| Age rating | 4+ | 4+ |
| Developer | [Korea Business News.Co.,Ltd.](https://appshunter.io/developer/510877799) | [Korea Investment & Securities Co., Ltd.](https://appshunter.io/developer/399315420) |

## What reviewers say

### 주식창 (주식, 증권시세, 주식비타민)

[App page](https://appshunter.io/ios/app/id577658269)

Access real-time stock market data, including quotes, charts, and expert analysis. Receive timely alerts for price changes and news, and engage with live financial broadcasts and consultations.

**Highlights:** Real-time stock quotes and charts, Customizable price and news alerts, Expert stock scoring (company, chart, supply/demand), Live financial broadcasts and radio, Real-time stock consultations, Extensive watchlist functionality

**Features:** Vision Pro support

**In-app purchases (5)**

| Purchase | Price | Billing |
| --- | --- | --- |
| 수급킹 유료 1개월 | $19.99 | one-time |
| 미국 퀀트 US Pick 1개월 단품 유료 | $59.99 | one-time |
| 원샷 유료 1개월 99,000 | $64.99 | one-time |
| Ai캐치 유료 1개월 | $119.99 | one-time |
| Ai캐치 유료 1개월 | $129.99 | one-time |


### 미니스탁

[App page](https://appshunter.io/ios/app/id1517001633)

Invest in domestic and international stocks with fractional shares starting from just 1,000 KRW. Enjoy real-time trading, automated investment options, and dividend reinvestment. Easily open accounts and access market insights and research.

**Highlights:** Fractional share investing, Real-time domestic and international stock trading, Automated investment options, Dividend reinvestment, Easy account opening, Market insights and research

**Features:** Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is 주식창 (주식, 증권시세, 주식비타민) free?

주식창 (주식, 증권시세, 주식비타민) is free to download, with in-app purchases available.

### Is 미니스탁 free?

미니스탁 is free to download, with no in-app purchases.

### Which has better reviews, 주식창 (주식, 증권시세, 주식비타민) or 미니스탁?

미니스탁 is rated higher. 주식창 (주식, 증권시세, 주식비타민) averages 2.9 out of 5 from 8 ratings, while 미니스탁 averages 4.0 from 22 ratings.

### Do 주식창 (주식, 증권시세, 주식비타민) or 미니스탁 have ads?

주식창 (주식, 증권시세, 주식비타민) shows ads; 미니스탁 does not.

### Which is updated more often, 주식창 (주식, 증권시세, 주식비타민) or 미니스탁?

주식창 (주식, 증권시세, 주식비타민) ships an update every 2 weeks, and 미니스탁 monthly. Most recently, 주식창 (주식, 증권시세, 주식비타민) was updated on November 16, 2026 and 미니스탁 on November 16, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*
